title: Poly-L-lysine-based molecular conjugate vectors: a high efficiency gene transfer system for human progenitor and leukemia cells.
abstract: BACKGROUND
  Targeted, specific receptor mediated gene transfer is a major goal of gene therapy research to accomplish gene transfer exclusively to the desired cell population.
  
  
  METHODS
  First, the use of natural receptor for stem cell factor and transferrin receptor-targeted gene transfer using poly-L-lysine-based molecular conjugate vectors was evaluated in a panel of hematopoietic progenitor cell lines. Second, the ability of poly-L-lysine to enhance adenovirus mediated gene transfer efficiency was examined in different cell lines by using recombinant adenovirus-poly-L-lysine molecular conjugate conglomerates (recMCVEGFP).
  
  
  RESULTS
  Despite effective ligand internalization receptor, gene expression amplification in receptor positive cell lines was not uniformly observed. Therefore, using a poly-L-lysine-based, receptor-targeted vector, neither transferrin nor natural receptor for stem cell factor mediated gene transfer can be considered a universally applicable procedure that exclusively depends on the presence of receptors on the cell surface; rather, it is a cell specific phenomenon. In our model, poly-L-lysine is the major contributor for gene transfer to hematopoietic progenitor cells, mediating the initial vector-cell binding. Human progenitor cell lines are poorly transduceable with recombinant adenovirus vectors. This new poly-L-lysine-modified, adenovirus-based vector could overcome virus tropism restrictions and consistently achieve very high transduction efficiency (>90%) in cells otherwise refractory to adenovirus gene transfer.
  
  
  CONCLUSIONS
  Polylysine-based adenovirus vectors may have promise for situations in which high-efficiency gene transfer with transient high level transgene expression in hematopoietic cells is needed, such as leukemia vaccine protocols or for purging strategies in leukemia cell contaminated stem cell preparations.
authors.affiliation: Department of Medicine, Louisiana State University Medical Center of New Orleans 70122, USA. pschwa1@lsuhsc.edu
authors.forename: P
authors.initials: P
authors.lastname: Schwarzenberger
authors.forename: W
authors.initials: W
authors.lastname: Huang
authors.forename: P
authors.initials: P
authors.lastname: Oliver
authors.forename: T
authors.initials: T
authors.lastname: Osidipe
authors.forename: C
authors.initials: C
authors.lastname: Theodossiou
authors.forename: J K
authors.initials: JK
authors.lastname: Kolls
mesh_terms: D000260:Adenoviruses, Human / Q000235:genetics*; D002289:Carcinoma, Non-Small-Cell Lung / Q000473:pathology; D002448:Cell Adhesion; D002460:Cell Line; D062727:Coxsackie and Adenovirus Receptor-Like Membrane Protein; D004705:Endocytosis; D005134:Eye Neoplasms / Q000473:pathology; D017930:Genes, Reporter; D005822:Genetic Vectors / Q000008:administration & dosage* / Q000235:genetics; D006412:Hematopoietic Stem Cells / Q000187:drug effects*; D006801:Humans; D020014:K562 Cells / Q000187:drug effects; D007947:Leukemia, Megakaryoblastic, Acute / Q000473:pathology; D007948:Leukemia, Monocytic, Acute / Q000473:pathology; D008175:Lung Neoplasms / Q000473:pathology; D014411:Neoplastic Stem Cells / Q000187:drug effects*; D011107:Polylysine / Q000008:administration & dosage / Q000494:pharmacology*; D019009:Proto-Oncogene Proteins c-kit / Q000187:drug effects; D011990:Receptors, Transferrin / Q000187:drug effects; D011991:Receptors, Virus / Q000187:drug effects; D012175:Retinoblastoma / Q000473:pathology; D014162:Transfection / Q000379:methods*; D014407:Tumor Cells, Cultured
chemical_list: C568771:CLMP protein, human; D062727:Coxsackie and Adenovirus Receptor-Like Membrane Protein; D011990:Receptors, Transferrin; D011991:Receptors, Virus; D011107:Polylysine; D019009:Proto-Oncogene Proteins c-kit